A Phase 1/2a - Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Healthy Volunteers and in Subjects With Chronic Hepatitis B Infection, Including Subjects With Chronic Hepatitis D Infection

Project: Research

Project Details

StatusNot started

Keywords

  • clinical trial
  • Hepatitis B
  • Hepatitis D
  • BJT-778